• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉侵犯:是肝细胞癌术后即刻复发的唯一最独立的危险因素。

Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.

机构信息

Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Gastroenterol Hepatol. 2011 Nov;26(11):1646-51. doi: 10.1111/j.1440-1746.2011.06780.x.

DOI:10.1111/j.1440-1746.2011.06780.x
PMID:21592228
Abstract

BACKGROUND AND AIM

Despite improvements of treatment in hepatocellular carcinoma (HCC), the recurrence rate after curative hepatic resection still remains remarkably high. An immediate recurrence of HCC after surgery is frustrating. We tried to clarify risks of immediate postoperative recurrence of HCC; that is, within 4 months after curative hepatic resection.

METHODS

A total of 167 patients with HCC underwent hepatic resection; 60 had immediate postoperative recurrences (IPR group), and 107 had disease-free survival for more than 5 years (DFS group). Variables were compared between the two groups.

RESULTS

Univariate analysis showed the following variables were significant risk factors for immediate postoperative recurrence of HCC: male sex, elevated serum aspartate aminotransferase level, greater amount of blood loss, longer operation time, worse tumor differentiation, higher tumor node metastasis stage, and presence of any of the following: intrahepatic metastasis, tumor-rupture, portal venous invasion, or microvascular invasion. In multivariate analysis, only portal venous invasion was a significant risk factor (odds ratio=3.2, P=0.03, standard error=0.5, Logistic regression analysis).

CONCLUSIONS

Portal venous invasion may be the most significant risk factor for immediate postoperative recurrence of HCC. However, accurate assessment of this risk factor may require histological examination, limiting its utility as a preoperative predictor. Further research is necessary to definitively identify preoperative predictors.

摘要

背景与目的

尽管肝细胞癌(HCC)的治疗有所改善,但根治性肝切除术后的复发率仍然很高。手术后 HCC 的即刻复发令人沮丧。我们试图阐明 HCC 即刻术后复发的风险;即在根治性肝切除术后 4 个月内。

方法

共有 167 例 HCC 患者接受了肝切除术;60 例发生即刻术后复发(IPR 组),107 例无病生存 5 年以上(DFS 组)。对两组间的变量进行比较。

结果

单因素分析显示,以下变量是 HCC 即刻术后复发的显著危险因素:男性、血清天门冬氨酸转氨酶水平升高、出血量较多、手术时间较长、肿瘤分化较差、肿瘤淋巴结转移分期较高、存在以下任何一种情况:肝内转移、肿瘤破裂、门静脉侵犯或微血管侵犯。多因素分析显示,只有门静脉侵犯是显著的危险因素(优势比=3.2,P=0.03,标准误=0.5,Logistic 回归分析)。

结论

门静脉侵犯可能是 HCC 即刻术后复发的最重要危险因素。然而,这种危险因素的准确评估可能需要组织学检查,这限制了其作为术前预测因素的实用性。需要进一步研究以明确术前预测因素。

相似文献

1
Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.门静脉侵犯:是肝细胞癌术后即刻复发的唯一最独立的危险因素。
J Gastroenterol Hepatol. 2011 Nov;26(11):1646-51. doi: 10.1111/j.1440-1746.2011.06780.x.
2
The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.术前血清乙肝e抗原阳性并不影响乙肝病毒相关肝细胞癌根治性切除术后的总生存期。
J Gastroenterol Hepatol. 2009 Mar;24(3):391-8. doi: 10.1111/j.1440-1746.2008.05637.x. Epub 2009 Nov 20.
3
Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.肝细胞癌门静脉侵犯的相关因素:232例未经术前治疗的手术切除病例的单因素和多因素分析
Cancer. 1996 May 15;77(10):2022-31. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S.
4
Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.与肝静脉主干接触的肝细胞癌患者肝静脉主干侵犯的预测因素及预后因素
J Hepatobiliary Pancreat Surg. 2007;14(3):289-96. doi: 10.1007/s00534-006-1142-0. Epub 2007 May 29.
5
[The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].[根治性切除术后门静脉化疗在延缓Ⅱ期原发性肝细胞癌肝内复发中的价值]
Ai Zheng. 2008 Dec;27(12):1297-301.
6
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.肝切除术后源于残留癌细胞的肝细胞癌复发的危险因素。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2469-75.
7
Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio.肝细胞癌微血管侵犯的预测因素:门静脉灌注缺损面积比的测量
J Gastroenterol Hepatol. 2009 Aug;24(8):1431-6. doi: 10.1111/j.1440-1746.2009.05847.x. Epub 2009 Apr 13.
8
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.肝细胞癌切除术后早期和晚期肝内复发的不同危险因素及预后
Cancer. 2000 Aug 1;89(3):500-7.
9
Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.影响肝细胞癌侵犯门静脉患者预后的因素——对952例连续性肝细胞癌患者的回顾性分析
Hepatogastroenterology. 2003 Nov-Dec;50(54):2035-9.
10
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.肝细胞癌患者的微血管侵犯及其可预测的临床病理因素。
Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7.

引用本文的文献

1
Comparison of Albumin-Bilirubin, Platelet-Albumin-Bilirubin, and Child-Pugh scores to predict overall survival in patients with stage C hepatocellular carcinoma with liver cirrhosis treated with c-TACE.比较白蛋白-胆红素、血小板-白蛋白-胆红素和Child-Pugh评分对经肝动脉化疗栓塞术(c-TACE)治疗的C期肝硬化肝细胞癌患者总生存期的预测价值。
Front Oncol. 2025 Aug 27;15:1613697. doi: 10.3389/fonc.2025.1613697. eCollection 2025.
2
Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma.免疫检查点抑制剂联合抗血管生成药物用于切除术后高危乙型肝炎病毒相关肝细胞癌患者的治疗
World J Gastrointest Oncol. 2025 Apr 15;17(4):101371. doi: 10.4251/wjgo.v17.i4.101371.
3
Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma.
根治性切除术后早期和多次复发对肝细胞癌的预后意义。
BMC Surg. 2024 Oct 29;24(1):339. doi: 10.1186/s12893-024-02642-6.
4
Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review.辅助性免疫检查点抑制剂能否改善肝切除术后具有高危复发因素的肝细胞癌的长期预后?一项荟萃分析和系统评价。
Front Oncol. 2024 May 24;14:1374262. doi: 10.3389/fonc.2024.1374262. eCollection 2024.
5
Refining MRI-based criteria for portal vein invasion in hepatocellular carcinoma: improving sensitivity beyond portal vein tumor thrombosis.细化基于 MRI 的肝细胞癌门静脉侵犯标准:提高超越门静脉癌栓的敏感性。
Abdom Radiol (NY). 2024 Feb;49(2):437-446. doi: 10.1007/s00261-023-04106-6. Epub 2023 Nov 21.
6
The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma.循环长杂合RNA在丙型肝炎相关肝细胞癌诊断和预后中的潜在作用
Noncoding RNA. 2023 Oct 11;9(5):62. doi: 10.3390/ncrna9050062.
7
Postoperative adjuvant tyrosine kinase inhibitors combined with anti-PD-1 antibodies improves surgical outcomes for hepatocellular carcinoma with high-risk recurrent factors.术后辅助酪氨酸激酶抑制剂联合抗 PD-1 抗体可改善具有高危复发因素的肝细胞癌的手术效果。
Front Immunol. 2023 Jun 8;14:1202039. doi: 10.3389/fimmu.2023.1202039. eCollection 2023.
8
Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child-Pugh Class B: a Retrospective Multicenter Study.Child-Pugh B级患者肝细胞癌的手术结局:一项回顾性多中心研究
J Gastrointest Surg. 2023 Feb;27(2):283-295. doi: 10.1007/s11605-022-05549-w. Epub 2022 Dec 5.
9
Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.磁共振成像的放射组学和列线图在小肝细胞癌微血管侵犯术前预测中的应用。
World J Gastroenterol. 2022 Aug 21;28(31):4399-4416. doi: 10.3748/wjg.v28.i31.4399.
10
A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma.经动脉化疗栓塞术(TACE)治疗肝细胞癌的应用综述。
J Family Med Prim Care. 2021 Oct;10(10):3553-3560. doi: 10.4103/jfmpc.jfmpc_2347_20. Epub 2021 Nov 5.